首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   2173693篇
  免费   174478篇
  国内免费   5860篇
耳鼻咽喉   30611篇
儿科学   67273篇
妇产科学   61706篇
基础医学   312458篇
口腔科学   60813篇
临床医学   194423篇
内科学   423999篇
皮肤病学   49962篇
神经病学   179552篇
特种医学   86644篇
外国民族医学   626篇
外科学   327090篇
综合类   52815篇
现状与发展   7篇
一般理论   730篇
预防医学   168918篇
眼科学   50964篇
药学   158840篇
  1篇
中国医学   5802篇
肿瘤学   120797篇
  2021年   18626篇
  2019年   18197篇
  2018年   25098篇
  2017年   19371篇
  2016年   22536篇
  2015年   26575篇
  2014年   36413篇
  2013年   52903篇
  2012年   72448篇
  2011年   75471篇
  2010年   44200篇
  2009年   41596篇
  2008年   67919篇
  2007年   71672篇
  2006年   71448篇
  2005年   69240篇
  2004年   66121篇
  2003年   63029篇
  2002年   60442篇
  2001年   98298篇
  2000年   100368篇
  1999年   83975篇
  1998年   24758篇
  1997年   22285篇
  1996年   22115篇
  1995年   20967篇
  1994年   19340篇
  1993年   18116篇
  1992年   65224篇
  1991年   62764篇
  1990年   60659篇
  1989年   57956篇
  1988年   53747篇
  1987年   52608篇
  1986年   49486篇
  1985年   47548篇
  1984年   36493篇
  1983年   30922篇
  1982年   19274篇
  1979年   34226篇
  1978年   24376篇
  1977年   20349篇
  1976年   19010篇
  1975年   19946篇
  1974年   24433篇
  1973年   23540篇
  1972年   22271篇
  1971年   20398篇
  1970年   19439篇
  1969年   18407篇
排序方式: 共有10000条查询结果,搜索用时 19 毫秒
41.
42.
43.
44.
Objective: Human epidermal growth factor receptor 2 (erbb2/HER2) overexpression, has now been implicatedin advanced gastric and gastroesophageal junction cancers. The study was conducted to determine the rate of HER2positivity in patients with locally advanced or metastatic gastric and gastroesophageal adenocarcinoma in North-EastIndia and to assess the impact of various demographic and clinical parameters on HER2 positivity. Methods: A total of68 patients of age >18 years of gastric and gastroesophageal adenocarcinoma diagnosed on histopathological examinationfrom September 2016 to February 2018 at Dr B Borooah Cancer Institute, Assam were enrolled for the observational(epidemiological) study. All patients were subjected to the HER2 immunohistochemistry test using a FDA-approved,standardized test kit. HER2 expression was correlated with various demographic and clinicopathological parameters.Results: The overall rate of HER2 positivity in the population studied was 56% (n=38). The rate was non-significantlyhigher in male, older age group (>60 years) and Hindu population. Similarly, HER2 positivity rate was higher in patientswith well differentiated histology and was more common in patients with stage II and III diseases, but neither of theassociations is statistically significant. HER2 positivity rate was significantly higher in proximal and in GEJ tumours(56% versus 44%, P=0.002). Conclusion: HER2 overexpression was evident in 56% of the North-East Indian patientswith locally advanced and metastatic gastric and gastroesophageal adenocarcinoma. The overexpression correlatedsignificantly with primary tumour site. Routine testing of gastric and gastroesophageal tumours for HER2 expressionis recommended to provide a therapeutic advantage in Indian patients.  相似文献   
45.

Objective

Comparative survival between neoadjuvant chemotherapy and adjuvant chemotherapy for patients with cT2-4N0-1M0 non–small cell lung cancer has not been extensively studied.

Methods

Patients with cT2-4N0-1M0 non–small cell lung cancer who received platinum-based chemotherapy were retrospectively identified. Exclusion criteria included stage IV disease, induction radiotherapy, and targeted therapy. The primary end point was disease-free survival. Secondary end points were overall survival, chemotherapy tolerance, and ability of Response Evaluation Criteria In Solid Tumors response to predict survival. Survival was estimated using the Kaplan–Meier method, compared using the log-rank test and Cox proportional hazards models, and stratified using matched pairs after propensity score matching.

Results

In total, 330 patients met the inclusion criteria (n = 92/group after propensity-score matching; median follow-up, 42 months). Five-year disease-free survival was 49% (95% confidence interval, 39-61) for neoadjuvant chemotherapy versus 48% (95% confidence interval, 38-61) for adjuvant chemotherapy (P = .70). On multivariable analysis, disease-free survival was not associated with neoadjuvant chemotherapy or adjuvant chemotherapy (hazard ratio, 1.1; 95% confidence interval, 0.64-1.90; P = .737), nor was overall survival (hazard ratio, 1.21; 95% confidence interval, 0.63-2.30; P = .572). The neoadjuvant chemotherapy group was more likely to receive full doses and cycles of chemotherapy (P = .014/0.005) and had fewer grade 3 or greater toxicities (P = .001). Response Evaluation Criteria In Solid Tumors response to neoadjuvant chemotherapy was associated with disease-free survival (P = .035); 15% of patients receiving neoadjuvant chemotherapy (14/92) had a major pathologic response.

Conclusions

Timing of chemotherapy, before or after surgery, is not associated with an improvement in overall or disease-free survival among patients with cT2-4N0-1M0 non–small cell lung cancer who undergo complete surgical resection.  相似文献   
46.
47.
Metabolism describes the series of chemical reactions that are concerned with the provision of energy to biological systems. They may be divided into reactions involved in energy yield (catabolism: demand exceeds supply), and energy storage (anabolism: supply exceeds demand). Regulation of these pathways is critical for homeostasis, and derangements in metabolism are seen in a wide variety of pathological processes. Understanding metabolism is key to the treatment of many diseases, notably diabetes, as well as underpinning clinical nutritional support.  相似文献   
48.
49.
50.
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号